Quick Answer
Evogene Ltd. reported Gross Profit of -$241.0 thousand for fiscal year 2025.
Evogene Ltd. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | -$241.0K | -107.5% |
| 2024 | $3.20M | +114.3% |
| 2023 | $1.49M | +94.8% |
| 2022 | $766.0K | +369.9% |
| 2021 | $163.0K | -65.0% |
| 2020 | $466.0K | +11.2% |
| 2019 | $419.0K | +42.0% |
| 2018 | $295.0K | -45.0% |
| 2017 | $536.0K | -40.5% |
| 2016 | $901.0K | -68.6% |
| 2015 | $2.87M | — |
- Evogene Ltd. showed a decrease of -107.5% in Gross Profit compared to the prior fiscal year.
- Over the 2015–2025 period, Evogene Ltd.’s gross profit has declined by 108.4% (from $2.87 million to -$241.0 thousand).
- The most recent figure is from Evogene Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: